Putnam Investments’s Histogen Inc. Common Stock HSTO Stock Holding History

Putnam Investments’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,414	Closed	-$2.79M	–	1347
2017 Q1	$2.79M	Buy	+2,414	New	+$2.33M	0.01%	784
2016 Q3	–	Sell	-953	Closed	-$392K	–	1373
2016 Q2	$392K	Hold	953	–	–	﹤0.01%	1231
2016 Q1	$408K	Hold	953	–	–	﹤0.01%	1282
2015 Q4	$549K	Hold	953	–	–	﹤0.01%	1297
2015 Q3	$848K	Sell	953 -130	-12%	-$118K	﹤0.01%	1209
2015 Q2	$1.11M	Sell	1,083 -1	-0.1%	-$1.17K	﹤0.01%	1203
2015 Q1	$1.54M	Sell	1,084 -5	-0.5%	-$6.34K	﹤0.01%	1112
2014 Q4	$1.52M	Hold	1,089	–	–	﹤0.01%	1110
2014 Q3	$1.33M	Buy	1,089 +2	+0.2%	+$2.87K	﹤0.01%	1140
2014 Q2	$1.98M	Buy	1,087 +1	+0.1%	+$1.34K	﹤0.01%	1030
2014 Q1	$1.77M	Sell	1,086 -6	-0.5%	-$12.5K	﹤0.01%	1075
2013 Q4	$1.41M	Sell	1,092 -2	-0.2%	-$3.19K	﹤0.01%	1134
2013 Q3	$2.2M	Buy	+1,094	New	+$2.03M	0.01%	1034

Other funds holding HSTO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Putnam Investments's HSTO Position: Q2 2017 in Review

Putnam Investments sold out of Histogen Inc. Common Stock (HSTO) in Q2 2017, closing a stake of 2,414 shares — an estimated $2.79M sold.

Putnam Investments first reported a position in HSTO in Q3 2013 and held it in 13 quarters. The position peaked at $2.79M in Q1 2017. 70 funds tracked by Wall St. Rank hold HSTO as of Q2 2017.

Putnam Investments reported no remaining Histogen Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Putnam Investments sold 2,414 Histogen Inc. Common Stock shares in Q2 2017, an estimated $2.79M.
Putnam Investments first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 13 quarters.
Putnam Investments's Histogen Inc. Common Stock position peaked at $2.79M in Q1 2017.
70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.